Phase 2A Open Label Safety Study of Fovista® (Anti-PDGF BB) Regimen Administered in Combination With Anti-VEGF Therapy to Study Sub-Retinal Fibrosis in Neovascular AMD
Clinical trial NCT02214628 · TERMINATED
Trial details
- NCT number
- NCT02214628
- Sponsor
- Ophthotech Corporation
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2016-12-01
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.